• Home
      • StockReports™Analyse your stocks in seconds
      • Stock ResearchExpert insight you can understand
      • StockRanks™Identify winning stocks
      • ScreenersGenerate investing ideas fast
      • PortfoliosMonitor and improve your performance
      • Charts and toolsTime your trades better
      • Academy
        • All topics
        • Analyse stocks
        • Discover stocks
        • Investment strategy
        • Portfolio management
      • Additional resources
        • Events
        • Product guides
        • Ratio glossary
        • Newsletter
        • Companies & markets
    • Reviews
    • Pricing
    • About
    Get startedLog in
    SectorsHealthcarePharmaceuticalsNeurocrine Biosciences
    Picture of Neurocrine Biosciences logo

    NBIX — Neurocrine Biosciences Share News

    $124.390.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapFalling Star
    • Market Cap
      $12.31bn
    • Enterprise Value
      $11.37bn
    • Revenue
      $2.36bn
    • Quality
      97
    • Value
      30
    • Momentum
      42
    • StockRank™
      57
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NBIX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NBIX Dividends
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      05/09/2022 09:00Announcement
    • REG - Stifel Nicolaus Euro Diurnal Group PLC Neurocrine Bio. - Form 8.5 (EPT/RI) - Diurnal Group plc

      02/09/2022 12:00Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      01/09/2022 18:30Announcement
    • REG - Stifel Nicolaus Euro Diurnal Group PLC Neurocrine Bio. - Form 8.5 (EPT/RI) - Diurnal Group plc

      01/09/2022 12:00Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      01/09/2022 09:00Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      31/08/2022 18:30Announcement
    • REG - Stifel Nicolaus Euro Diurnal Group PLC Neurocrine Bio. - Form 8.5 (EPT/RI) - Diurnal Group plc

      31/08/2022 12:00Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      31/08/2022 09:00Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      30/08/2022 18:16Announcement
    • REG - Takeover Panel - Disclosure Table (POTAM only)

      30/08/2022 09:00Announcement
    • REG - Diurnal Group PLC Neurocrine Bio. - RECOMMENDED CASH ACQUISITION

      30/08/2022 07:16Announcement
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2025, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.